SMA Foundation
E561094
The SMA Foundation is a nonprofit organization dedicated to accelerating the development of treatments for spinal muscular atrophy through funding and collaborative research.
All labels observed (1)
| Label | Occurrences |
|---|---|
| SMA Foundation canonical | 1 |
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
medical research foundation
ⓘ
nonprofit organization ⓘ |
| aimsTo |
accelerate therapy development timelines
ⓘ
bridge gaps between basic research and clinical application ⓘ improve outcomes for people with spinal muscular atrophy ⓘ |
| benefits |
families affected by spinal muscular atrophy
ⓘ
patients with spinal muscular atrophy ⓘ |
| collaboratesWith |
academic medical centers
ⓘ
industry partners ⓘ patient advocacy groups ⓘ |
| conductsActivity |
clinical research support
ⓘ
drug discovery support ⓘ funding research ⓘ preclinical research support ⓘ supporting collaborative research ⓘ |
| field |
biomedical research
ⓘ
neuromuscular disease research ⓘ rare disease research ⓘ |
| focusesOnDisease | spinal muscular atrophy ⓘ |
| fundingModel |
grants to research institutions
ⓘ
philanthropic donations ⓘ |
| goal |
advance the scientific understanding of spinal muscular atrophy
ⓘ
bring effective therapies for spinal muscular atrophy to patients as quickly as possible ⓘ enable development of multiple therapeutic approaches for spinal muscular atrophy ⓘ |
| hasFullName | Spinal Muscular Atrophy Foundation NERFINISHED ⓘ |
| hasMission | to accelerate the development of treatments for spinal muscular atrophy ⓘ |
| hasTargetPopulation |
adults with spinal muscular atrophy
ⓘ
children with spinal muscular atrophy ⓘ |
| nonprofitType | disease-focused foundation ⓘ |
| operatesAs | 501(c)(3) organization ⓘ |
| researchArea |
gene-based therapies for spinal muscular atrophy
ⓘ
motor neuron biology in spinal muscular atrophy ⓘ muscle function in spinal muscular atrophy ⓘ neuroprotective strategies for spinal muscular atrophy ⓘ small-molecule therapies for spinal muscular atrophy ⓘ |
| supports |
biomarker development for spinal muscular atrophy
ⓘ
clinical trial readiness in spinal muscular atrophy ⓘ drug screening for spinal muscular atrophy ⓘ natural history studies of spinal muscular atrophy ⓘ therapeutic target identification for spinal muscular atrophy ⓘ translational research in spinal muscular atrophy ⓘ |
| usesApproach |
collaboration with academic researchers
ⓘ
collaboration with biotechnology companies ⓘ collaboration with pharmaceutical companies ⓘ public–private partnerships ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.